Citicoline - the first effective neuroprotectant to be combined with thrombolysis in acute ischemic stroke?

Journal of the Neurological Sciences

Volumn 247, Issue 2, 2006, Pages 119-120

  Overgaard, Karsten ^a   Meden, Per ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CITICOLINE; DISUFENTON SODIUM; DIZOCILPINE; NEUROPROTECTIVE AGENT; TISSUE PLASMINOGEN ACTIVATOR;

BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG EFFECT; EDITORIAL; HEART INFARCTION SIZE; HUMAN; MORTALITY; NEUROPROTECTION; PRIORITY JOURNAL; REPERFUSION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ANIMALS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; CYTIDINE DIPHOSPHATE CHOLINE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; HUMANS; NEUROPROTECTIVE AGENTS; THROMBOLYTIC THERAPY;

EID: 33748179810     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.05.042     Document Type: Editorial

References (14)

1. Boismare F., Le Poncin M., Lefrancois J., and Lecordier J.C. Action of cytidine diphosphocholine on functional and hemodynamic effects of cerebral ischemia in cats. Pharmacology 17 (1978) 15-20
2. Schabitz W.R., Li F., Irie K., Sandage Jr. B.W., Locke K.W., and Fisher M. Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. Stroke 30 (1999) 427-431 [discussion 431-2]
3. Onal M.Z., Li F., Tatlisumak T., Locke K.W., Sandage Jr. B.W., and Fisher M. Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats. Stroke 28 (1997) 1060-1065
4. Andersen M., Overgaard K., Meden P., Boysen G., and Choi S.C. Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model. Stroke 30 (1999) 1464-1471
5. Shuaib A., Yang Y., and Li Q. Evaluating the efficacy of citicoline in embolic ischemic stroke in rats: neuroprotective effects when used alone or in combination with urokinase. Exp Neurol 161 (2000) 733-739
6. deLeciñana M.A., Gutiérrez M., Roda M., Carceller F., and Diez-Tejedor E. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke. J Neurol Sci 247 (2006) 121-129 10.1016/j.jns.2006.03.022
7. Dávalos A., Castillo J., Álvarez-Sabín J., Secades J.J., Mercadal J., López S., et al. Oral citicoline in acute ischemic stroke. Stroke 33 (2002) 2850-2857
8. Clark W.M., Warach S.J., Pettigrew L.C., Gammans R.E., and Sabounjian L.A. A randomised dose-response trial of citicoline in acute ischemic stroke patients. Neurology 49 (1997) 671-678
9. Clark W.M., Williams B.J., Selzer K.A., Zweifler R.M., Sabounjian L.A., and Gammans R.E. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke 30 (1999) 2592-2597
10. Warach S., Pettigrew L.C., Dashe J.F., Pullicino P., Lefkowitz D.M., Sabounjian L., et al. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 48 (2000) 713-722
11. Clark W.M., Wechsler L.R., Sabounjian L.A., Schwiderski U.E., and for the Citicoline Stroke Study Group. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology 57 (2001) 1595-1602
12. Secades J.J., D{stroke}lvarez-Sabín J., Rubio F., Lozano R., Dávalos A., Castillo J., and for the Trial Investigators. Citicoline in intracerebral haemorrhage: a double-blind, randomized, placebo-controlled, multi-centre pilot study. Cereb Dis 21 (2006) 380-385
13. Tilley B.C., Marler J., Geller N.L., Lu M., Legler J., Brott T., et al. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke 27 (1996) 2136-2142
14. Lees K.R., Zivin J.A., Ashwood T., Davalos A., Davis S.M., Diener H.C., et al., for the Stroke-Acute Ischemic NXY Treatment (SAINT I) Trial Investigators. NXY-059 for Acute Ischemic Stroke. NEJM 354 (2006) 588-600